GROUP CNIO-TM

Dra. Eva Gonzalez is PhD in Molecular Biology, is a Senior scientist and group leader of the Transformation and Metastasis laboratory, at the Spanish National Cancer Research Center (CNIO) in Madrid, Spain.

Her academic merits and research have been recognized with an ERC-Consolidator grant, ERC-Proof of Concept, a Susan Komen career catalyst grant, overlapping grants from multiple public and private agencies, and several awards. She is member of experts committee in several institutions as the Agencia Estatal de Investigación, European network of breast development and cancer (ENBDC), among others, and has supervised several PhD students and postdocs.  

Research in her laboratory aims to identify novel targets for breast cancer treatment and understand mechanisms of resistance to current drugs. She has more than 50 publications, half of them in D1 and half as corresponding author.

To highlight a topic of her extensive research career, one of her main contributions of research has focused on the role of RANK in mammary epithelial homeostasis, breast cancer and tumor immunology, with studies from basic to clinical research. She coordinates a clinical trial in breast cancer patients.

GROUP RESEARCHERS

Staff researchers

  • Maria Jiménez, contrato indefinido en CNIO, con amplia experiencia internacional en oncología,  inmunología tumoral y bioinformática.
  • Sofia Carbajosa, contrato indefinido en CNIO, cexperiencia en screening celulares.

Postdoctoral Research

  • Macarena Pozo, contrato Juan de la Cierva, experta en metabolismo celular.
  • Alejandro Collado-Sole, experiencia en desarrollo mamario y regulación neuroendocrina.
  • Alexandra Barranco, experta en inmunología tumoral.

PhD students

  • Alejando Sanchez-Juan (contrato a cargo de SenesceX-CM), experiencia en biologia mamaria y senescencia.
  • Maria Aranzazu Gomez, desde 2023, contrato CAM, PIPF-2022SAL-GL-26079., experiencia
    en metabolismo tumoral.
  • Xavier Thillen, desde 2025, contrato CAM, PIPF-2024/SAL-GL-35534, experiencia en senescencia y screenings celulares.
  • Mario Rodriguez del Collado, desde 2024 – contrato FPU, FPU23/02826, experiencia en
    metastasis.
  • Alba Calero, desde 2025 contrato FPI, experiencia en regulación endocrina.

clinical oncologist

  • Andrea C Vethencourt, contrato Río Hortega, contrato ICO

Technical

  • Víctor López, contrato CNIO con cargo a proyecto.técnico de animales.

Collaborators

Oncólogos médicos: Sonia Pernas, Catalina Falo, contrato indefinido Instituto Catalán de Oncología, Hospital de Bellvitge.

PROJECTS (LAST 5 YEARS)

  • ERC-2024- Proof of Concept Grant. Eva Gonzalez-Suarez (PI). Targeting intracelular
    RANKL in breast cancer. Intra-Rankl. European Research Council. 150,000 €. 2025 – 2026
  • PID2023-152798OB-I00. Spanish Ministry of Science and Innovation. Menopausia y cancercomo regulador metabólico. Eva Gonzalez Suarez PI, 387500 € + Predoctoral contract. PREP2023-001518. 2025-2027 (A Calero)
  • Caixa Research Health 2023 Grants. MYELO-RANK HR23-00361. Role of Rank in myeloid cells and tumor development. La Caixa Foundation 499,000 €. Role PIs: 2023-2026.
  • P2022/BMD-7393 Consorcio CAM. SenesceX-CM. Senescencia celular en fisiología y enfermedad. Comunidad de Madrid 828,000 €, 220,803 € for my team. Role Coordinator: 2023-2026.
  • ERC-2021- Proof of Concept Grant. Target-Rank. European Research Council. 150,000 €, 2023-2024.
  • PID2020-116441GB-I00. Systemic and myeloid RANK in mammary epithelial homeostasis and cancer, beyond its epithelial role. 327362 €. Spanish Ministry of Science and Innovation. AEI. 2021-2023.
  • Identification of mechanisms of response to CDK4/6 inhibition in hormone receptor positive breast cancer. FUNDACIÓN MARATÓ TV3. 2020-2023. Coordinador: A Prat. PIs: A Prat, R Gomis & E Gonzalez-Suarez. 400,000 € (100,000 € for my group) 2020-2023.
  • ERC Consolidator Grant. Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity. PLEIO-RANK. 1,999,999 € European Research Council. 2016-2021. Extended till 2023.

THESIS  (LAST 5 YEARS)

  • Andea C Vethencourt, oncóloga médica, Universidad de Barcelona, defensa en Marzo 2026.
  • Jaime Redondo Pedraza. Universidad Autónoma de Madrid (UAM). Excellent Cum Laude, julio 2025.
  • Alejandro Collado Solé. Universidad Autónoma de Madrid (UAM), Spain. Excellent Cum Laude, mayo 2025.
  • Alexandra Barranco,, Universidad de Barcelona. Sobresaliente Cum Laude, octubre 2024.
  • Marina Ciscar, Universidad de Barcelona. Sobresaliente Cum Laude octubre 2022,
  • Clara Gomez-Aleza, Universidad de Barcelona. Sobresaliente Cum Laude, octubre 2021.
  • Sandra Benitez, Universidad de Barcelona. Sobresaliente Cum Laude, enero 2021

RELEVANT PUBLICATIONS

MERITS & RESPONSIBILITIES

Member of networks and committees
  • ENBDC | European Network for Breast Development and Cancer (Comité Científico), desde 2011.
  • EurOPDX (https://www.europdx.eu/), desde 2014.
  • ASEICA.
  • Sociedad Española de Senescencia Celular (miembro fundador), desde 2023.
  • Oficina de Igualdad (CNIO).
  • Dean’s Office / Oficina de Asuntos Académicos del Decano (CNIO).
  • Coorganizadora de actividades para estudiantes del CNIO, incluyendo CNIO Lab Day.
  • Editorial Board, Journal of Mammary Gland Biology and Neoplasia (JMGBN), desde 2020.
  • Coordinadora de la Red de Excelencia “Senescencia celular: de mecanismos a terapias” (2017-2019).
Organization of congresses and scientific meetings
  • CNIO Frontiers Meeting on epithelial plasticity (2027).
  • Gordon Research Conference on mammary gland biology (2026).
  • Workshop SenesceX (Madrid, 2024).
  • CNIO Frontiers Meeting on metastasis (2023).
    External reviewer for
    • Revisora externa para Nature Metabolism.
    • Revisora externa para Cell Metabolism.
    • Revisora externa para Nature Aging.
    • Revisora externa para Nature Cell Biology.
    • Revisora externa para otras revistas científicas internacionales de alto impacto.
    External evaluator for national and international agencies
    • Institut National du Cancer (France).
      Ministerio de Educación y Ciencia de Argentina (PICT, Argentina).
    • Breast Cancer Campaign (UK).
      Dr Hayden Trust for Human Research (UK).
    • Swiss National Science Foundation (SNSF, Switzerland).
    • Research Foundation Flanders (FWO, Belgium).
      Instituto de Medicina Molecular iMM (Portugal).
      Israel Cancer Foundation.
    • French National Institute of Cancer (France).
      Fondazione AIRC per la Ricerca sul Cancro ETS (Italy).
    • Worldwide Cancer Research (UK).
      ERC Starting and Consolidator Grants.
    Member of evaluation panels in
    • ISCIII y AEI.
    • ANEP (Spanish National Evaluation Agency).
    • SAF grants (desde 2012).
    • FIS Health grants (2008-2012).
    • Miguel Servet contracts (2010-2012).
    • Juan de la Cierva contracts (2015-2016).
    • Ramón y Cajal contracts (2017).
    • MINECO panels (2014, 2019, 2020).
    • Spanish Association Against Cancer (proyectos regionales en Andalucía, Castilla y León, Comunidad Valenciana).
    • Fundación Disa.
    • Fundación Vasca.
    • Fundación Sandra Ibarra.
    • Fundación Inocente.

    CONSORTIUM FINANCED BY:

    Contact: 91 999 99 99 | contact@proyect.com